Computachem 
          Editor's Note:
          We are pleased to announce that we have formed an alliance with Health 
          Communications Network (HCN), an Australian company that is heavily 
          involved in e-health. With permission, we have extracted two items from 
          their recent newsletter which should prove of interest to pharmacists. 
          
          Note that the second item, the top 20 prescriptions written by GP's 
          is provided by the GPRN database noted above.
        The 
          medication in focus this week is Salbutamol sulfate.
         
          Prescribing of asthma medications
         
          Data used: GPRN database 
          Data range: Prescriptions written between 1 Jan 1999 - 30th September 
          2001 Number of prescriptions: 24,938 
          
          Patient profile 
          
          Number of patients: 16,395 
          Sex: 46 percent male; 54 percent female 
          Age 15 percent patients aged less than 10; 21 percent of patients 
          aged 10-24. 
        
        
          Reasons for prescribing Salbutamol sulfate inhaler 
        The 
          top ten indications for the prescription of salbutamol sulfate inhaler 
          are shown in Figure 3. 
          The majority of prescriptions were for asthma (80 percent), around 4 
          percent were written for COAD (the term COPD was also recorded as a 
          reason, in around one percent of prescriptions).
        
        Top 
          20 Medications prescribed in General Practice this week 
        
           
            |   | 
            This 
              Month | 
            Last 
              Month | 
            This 
              Year | 
          
           
            | Generic 
              medication | 
            Rank | 
            Percent | 
            Rank | 
            Percent | 
            Rank | 
            Percent | 
          
           
            | Amoxycillin | 
            1 | 
            4.24 | 
            1 | 
            4.2 | 
            4 | 
            2.67 | 
          
           
            | Temazepam | 
            2 | 
            3.34 | 
            3 | 
            3.2 | 
            1 | 
            3.38 | 
          
           
            | Paracetamol | 
            3 | 
            3.18 | 
            4 | 
            3.1 | 
            3 
               | 
            3.08 | 
          
           
            | Paracetamol/codeine 
              phosphate | 
            4 | 
            3.17 | 
            2 | 
            3.3 | 
            2 | 
            3.21 | 
          
           
            | Amoxycillin/potassium 
              clavulanate | 
            5 | 
            2.08 | 
            7 | 
            1.7 | 
            12 | 
            1.39 | 
          
           
            | Roxithromycin | 
            6 | 
            2.06 | 
            5 
               | 
            1.9 | 
            13 
               | 
            1.37 | 
          
           
            | Salbutamol 
              sulfate  | 
            7 | 
            1.89 | 
            6 | 
            1.8 | 
            7 | 
            1.71 | 
          
           
            | Cephalexin | 
            8 | 
            1.71 | 
            10 | 
            1.6 | 
            8 | 
            1.69 | 
          
           
            | Diazepam | 
            9 | 
            1.65 | 
            9 | 
            1.6 | 
            6 | 
            1.78 | 
          
           
            | Celecoxib | 
            10 | 
            1.58 | 
            13 | 
            1.5 | 
             
              5  | 
            2.12 | 
          
           
            | Cefaclor | 
            11 | 
             
              1.49 | 
            11 
               | 
            1.5 | 
            17 | 
            1.13 | 
          
           
            Levonorgestrel/ 
               
              ethinyloestradiol  | 
            12 | 
            1.44 | 
            8 
               | 
            1.6 | 
            10 | 
            1.56 | 
          
           
            | Oxazepam 
               | 
            13 | 
            1.32 | 
            14 | 
            1.3 | 
             
              9  | 
            1.56 | 
          
           
            | Atorvastatin 
               | 
            14 | 
            1.29 
               | 
            17 | 
            1.3 
               | 
            15 | 
            1.26 | 
          
           
            | Simvastatin 
               | 
            15 | 
            1.28 | 
            16 | 
            1.3 | 
            14 | 
            1.33 | 
          
           
            | Doxycycline 
               | 
            16 | 
            1.24 | 
            12 
               | 
            1.5 | 
            18 | 
            1.11 | 
          
           
            Ranitidine 
              hydrochloride  | 
            17 | 
            1.14 | 
            15 | 
            1.3 | 
            11 | 
            1.52 | 
          
           
            | Rofecoxib 
               | 
            18 | 
            1.13 | 
            18 | 
            1.3 | 
            39 | 
            0.62 | 
          
           
            | Aspirin 
               | 
            19 | 
            1.10 | 
            20 | 
            1.0 | 
            19 | 
            1.10 | 
          
           
            | Mometasone 
              Furoate  | 
            20 | 
            1.09 | 
            19 | 
            1.2 | 
            21 
               | 
            1.06 | 
          
        
         
         
         
         
         
         
         
         
         
         
         
         
        
          
          This 
          month = four weeks ending 30 September 2001 
          Last month = four weeks ending 2 September 2001 
          This year = 1 October 2000 to 30 September 2001
          Last data supplied: 30 September 2001
          Data source: GPRN Health Communication Network 
        Editorial 
          Review:
          Geoffrey Sayer * Dr Frank Pyefinch 
          Contributing Authors:
          Fiona Horn * Leigh Hendrie * Kevin McGeechan * Geoffrey Sayer 
          Editor:
          Alice Bhasale
          Health Communication Network, PO Box 67 St Leonards NSW 1590 ph 02 9906 
          6633 
          email: research@hcn.com.au.
        Back 
          to Article Index
          Newsletter 
          Reader's Forum 
           
          
        
           
             
                
                Previous Article 
                  
             | 
             
               
                  
                Next Article  
             | 
          
        
        
           
            |  
                 
               
                The 
                  comments and views expressed in the above article are those 
                  of the author and no other. The author welcomes any comment 
                  and interaction, directly or via the Newsletter Reader's Forum 
                  links located at the top and bottom of each article. 
               
             | 
          
           
             
               
                The 
                  newsletter archives are now fully searchable via the search 
                  engine on the left hand side of this page. If you would like 
                  to find similar articles to the above material, please enter 
                  the appropriate keyword(s). To retain context with multiple 
                  keywords or phrases, please enclose in inverted commas. 
               
             | 
          
           
            |  
               * 
                 
                Please contact us if you would like further information or would 
                like us to research additional material to publish as future articles. 
             | 
             
               * 
                 
                Don't forget to advise of any change in your e-mail address so 
                that your subscription may be continued without interruption. 
                 
             | 
             
               * 
                Letters to the editor are encouraged, or if you have material 
                you would like published, please forward to the editor.  
             | 
             
               * 
                 
                Any interested persons who would like to receive this free newsletter 
                on their desktop each fortnight, please send a single word e-mail 
                "Subscribe" 
             | 
             
               * 
                 
                If you have found value in this newsletter, please share it with 
                a friend, or alternatively, encourage a colleague to subscribe 
                 
             | 
          
           
            |  
              
             | 
          
           
             
              * 
                You are invited to visit the Computachem web site and check out 
                an organised reference site for medical or other references.  
                Why not try (and bookmark) the  
                Computachem Interweb Directory  
                for an easily accessed range of medical 
                and pharmacy links, plus a host of pharmacy relevant links.  
                The directory also contains a very fast search engine for Internet 
                enquiries. You may also access the Home Page at: 
                http://www.computachem.com.au 
             | 
          
        
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
         
        Back 
          to Article Index
          Article 
          Archive 2000
          Article 
          Archive 2001
          Home